Media stories about National Health Investors (NYSE:NHI) have trended somewhat positive on Thursday, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. National Health Investors earned a news sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the real estate investment trust an impact score of 46.8212351693604 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Here are some of the headlines that may have effected Accern’s rankings:
- On Friday National Health Investors, Inc. (NHI) stock price settles at $66.31 with movement of 0.47% (nasdaqexpress.com)
- National Health Investors, Inc. (NHI) Ex-Dividend Date Scheduled for March 28, 2018 (nasdaq.com)
- BMO Capital Markets Analysts Give National Health Investors (NHI) a $70.00 Price Target (americanbankingnews.com)
- Why the National Institute of Health New Budget Looks So Promising (msn.com)
- National Health Investors Inc (NHI) Receives Average Recommendation of “Hold” from Analysts (americanbankingnews.com)
Shares of NHI stock traded down $0.46 during trading hours on Thursday, hitting $67.29. The company had a trading volume of 283,972 shares, compared to its average volume of 281,182. National Health Investors has a 12 month low of $62.71 and a 12 month high of $81.60. The firm has a market cap of $2,758.98, a P/E ratio of 17.51, a P/E/G ratio of 3.42 and a beta of 0.48. The company has a current ratio of 13.85, a quick ratio of 13.85 and a debt-to-equity ratio of 0.87.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 10th. Investors of record on Friday, March 30th will be given a dividend of $1.00 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This is a positive change from National Health Investors’s previous quarterly dividend of $0.95. This represents a $4.00 dividend on an annualized basis and a yield of 5.94%. National Health Investors’s dividend payout ratio is 98.19%.
A number of research analysts have commented on the company. KeyCorp restated an “underweight” rating on shares of National Health Investors in a research note on Tuesday, December 19th. Mizuho reaffirmed a “hold” rating and issued a $70.00 price target on shares of National Health Investors in a research report on Monday, February 26th. BMO Capital Markets set a $70.00 price target on National Health Investors and gave the stock a “hold” rating in a research report on Monday. Stephens set a $79.00 price objective on National Health Investors and gave the stock a “buy” rating in a research report on Friday, January 12th. Finally, SunTrust Banks set a $70.00 price objective on National Health Investors and gave the stock a “hold” rating in a research report on Saturday, February 17th. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. National Health Investors currently has a consensus rating of “Hold” and an average target price of $76.50.
In other news, CEO D. Eric Mendelsohn acquired 2,000 shares of National Health Investors stock in a transaction on Thursday, February 22nd. The shares were purchased at an average price of $65.47 per share, with a total value of $130,940.00. Following the acquisition, the chief executive officer now owns 10,580 shares in the company, valued at $692,672.60. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, VP John L. Spaid purchased 500 shares of the business’s stock in a transaction dated Thursday, February 22nd. The stock was bought at an average cost of $64.95 per share, for a total transaction of $32,475.00. Following the purchase, the vice president now owns 971 shares in the company, valued at $63,066.45. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 2,812 shares of company stock worth $183,910. 5.19% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: “National Health Investors (NYSE:NHI) Earns Coverage Optimism Rating of 0.12” was first reported by BBNS and is owned by of BBNS. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at https://baseballnewssource.com/2018/03/29/national-health-investors-nhi-getting-somewhat-positive-news-coverage-study-shows/1971307.html.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.